“Fractionalized BD” Integrated BD / Social Marketing Program

to Increase BD pipeline and BD-ROI

Presented By James J. Sarene Managing Director & Founder BioAlliance Strategies, LLC Office: +1 919-386-1666 Mobile: +1 704-293-7162 james.sarene@bioalliancestrategies.com www.bioalliancestrategies.com

INTRODUCTION This strategic document is intended to define basic operational assumptions and considerations for the creation of an integrated Business Development / Social Marketing support program that resonates in a Global Market. BioAlliance Strategies’ deliverables: Market Outreach

Manage Twitter account and activity: 5-6 daily tweets with 2-3 specific topics providing links to website, LinkedIn profiles and Slideshare

Create weekly “Share Update” for employees providing links to website, Twitter and Slideshare

Business Development Ø  Provide thousands of validated sponsor/CRO contacts Ø  Create and Communicate capabilities and materials to your target market through multiple channels

Monthly presentation created providing links to website, LinkedIn profiles and Twitter

Monthly / Quarterly newsletter created providing links to website, LinkedIn profiles and Twitter

Report to BD teams with data of “Opens and Clicks”

“Fractionalized BD” Model

The BioAlliance Model BioAlliance Strategies was created specifically to meet growing demand for cost-effective business development services within clinical research industry. The BioAlliance approach emphasizes research, value-based differentiation, strategic planning, tactical movement, and professional execution. Your business development process begins with creation of customized campaigns that evaluate prospective relationships on the basis of primary alignments, such as: Ø  Therapeutic, phase and operational expertise Ø  Access to desired populations and geographic regions Ø  Development phase and Geographic reach Ø  Demand: Expertise and capacity Ø  Existing relationships: Industry, professional, academic

BioAlliance works ‘under’ your BD team by increasing territory contacts and creating more opportunities for each individual on the team. Your BD team is more ‘client facing’ which earns more ‘shots on goal’ and can earn more money which reduces your turn-over. A smaller team saves payroll, taxes and healthcare costs. Win-Win!

INTEGRATED BD/MARKETING PROCESS

Due Diligence Capabilities

Differentiators

Marketing Calendar &

Strategy Positioning

Plan Monthly Topics / Industry Events

Contact Database

Existing CRM / Contacts Provided

Content Development /

Distribution

Reporting Metrics and

Data: Opens / Clicks

Due Diligence BioAlliance Strategies works to identify key differentiators that are communicated to targeted industry decision makers and influencers. Descriptive tag lines and phrases are developed and leveraged that will resonate in the market in order to build your brand identity and awareness. This information is repurposed throughout all of our supporting efforts in order to educate your targets and build brand identity.

Marketing Calendar and Strategy Once your differentiators and capabilities are identified, we work together to build a BD/Marketing Calendar to map out timelines for specific relevant and timely communication topics that align with industry events such as “Partnerships with CROs, DIA, BIO, SCDM, ISCTM” etc.

Business Development / Marketing CalendarQ3 - 2014 Wk 1 Wk 2 Wk 3 Wk 4 Wk 5 Wk 6 Wk 7 Wk 8 Wk 9 Wk 10 Wk 11 Wk 12 Wk 13

Campaign 4-Aug 11-Aug 18-Aug 25-Aug 1-Sep 8-Sep 15-Sep 22-Sep 29-Sep 6-Oct 13-Oct 20-Oct 27-Oct

Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter

LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn

Email

Newsletter Newsletter Newsletter Newsletter

Blog

Data Report Data Data Data

Slideshare Slideshare Slideshare Slideshare

Industry Event

Team Teleconferences TC TC TC TC TC TC TC TC TC TC TC TC TC

Q4- 2014 Wk 1 Wk 2 Wk 3 Wk 4 Wk 5 Wk 6 Wk 7 Wk 8 Wk 9 Wk 10 Wk 11 Wk 12 Wk 13

Campaign 3-Nov 10-Nov 17-Nov 24-Nov 1-Dec 8-Dec 15-Dec 22-Dec 29-Dec 5-Jan 12-Jan 19-Jan 26-Jan

Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter Twitter

LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn LinkedIn

Email

Newsletter Newsletter Newsletter Newsletter

Blog

Data Report Data Data Data

Slideshare Slideshare Slideshare Slideshare

Industry Event

Team Teleconferences TC TC TC TC TC TC

Contact Database BioAlliance Strategies will leverage your existing CRM database and provides high-value, high-probability prospects from our existing database of up to 8K contacts. Sample - San Francisco: Cardiovascular & Dermatology Sample of 109 companies

Content Development and Distribution BioAlliance Strategies will develop content for Newsletters and Emails that offer industry insight, demonstrate operational capabilities and position you as a company that cares. This communication strategy maintains a market presence leveraging industry accepted content and an outreach cadence to position your company as a valuable resource.

Monthly Newsletter

BioAlliance Strategies will create a monthly newsletter outlining your services and capabilities, distribute to targeted contacts via industry recognized platforms and report the reader’s activities to your BD team. This report will create a valuable call/email sheet for follow up activities to individuals who have taken some action from your communication to them. Sample Newsletter: Please review a Sample Newsletter that outlines a client’s monthly topic and several sub-topics. The goal of the newsletter is to have the look and feel of your website. So when a reader clicks on a link, it takes them to a corresponding page/picture on your website. This approach builds your brand recognition and presents a very professional image.

Stereology Stereology involves the quantitative assessment of objects in three dimensions. Examples of measurements that can be obtained include total cell count, cell density, cell size, tissue volume, and the length density and/or total length of linear structures such as nerve process or blood vessels. Current design-based stereological methods have evolved to provide results that are unbiased, efficiently obtained, and repeatable.

Reporting: “Metrics and Data” Once Newsletters and Emails have been distributed to targeted industry decision makers and influencers, BioAlliance reports all “Opens and Clicks” of contacts who reviewed your materials and went to your website, LinkedIn profiles, Twitter and Slideshare accounts. This Excel spreadsheet becomes a powerful tool for ‘warm’ follow up calls and emails with people you know have expressed some interest by actions they have taken. This focuses BD teams toward individuals who are more aware of your company and more likely to be responsive. This validated data is now uploaded into your CRM keeping it accurate. Trending Opens

Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul TotalTwitter 133 221 205 559 Open % 61% 44% 32% 46%Slideshare 223 101 186 74 584 Emailed 11,171 8,941 8,980 8,915 38,007 Opens 1,714 925 1,106 1,315 5,060 Total Opens 2,315 1,626 1,631 1,721 7,293 Single % 15.3% 10.3% 12.3% 14.8% #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 13.3%Total % 20.7% 18.2% 18.2% 19.3% #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 19.2%

11,171  

8,941   8,980   8,915  

1,714  925   1,106   1,315  

2,315  1,626   1,631   1,721  

-­‐

2,000  

4,000  

6,000  

8,000  

10,000  

12,000  

Aug Sep Oct Nov   Dec Jan Feb Mar Apr May Jun Jul

Chart  Title

Emailed

Opens

Total  Opens

Experience Professionals

Managing Director & Founder: James J. Sarene has over 18 years experience in the Life Sciences working with companies from emerging biotech to large pharmaceuticals. With special expertise in Business Development, M&A and Licensing, Mr. Sarene was Managing Director at Madison Keats, a boutique Charlotte based transactional firm, where he focused on providing clients with strategic partnerships enabling growth opportunities. More Managing Director: Jared Byer, MBA manages business development and marketing program strategies and execution. Jared is a communications and business development professional with over 15 years of experience in the clinical research industry. Earlier experience includes positions as a technical writer for a leading environmental testing company and as a writer for The Kansas City Times. More Managing Director: Munaf Ali, Ph.D. obtained his PhD at Imperial College, University of London in 1987 in the field of Molecular Virology. Dr. Ali has over 20 years of experience in regulatory affairs and CNS drug development. From 1996 to 1999, Dr. Ali was a principal scientific reviewer at MHRA, including membership in the European Biotech Working Party and CHMP representative for the UK at the European Medicines Agency (EMA). More

Advisors: Operational, Scientific and Technology

Patrick R. Ayd, BSN, MBA – Advisor, Clinical Sites Bio

Romano Robusto, LLB, B.CL., B.Sc. – Advisor, Medical Devices Bio

Richard M. Hahn – Advisor, Marketing / Webdesign Bio

Karen Watson-Robin – Advisor, Strategic Sales Bio

Andrew L. Johnson, Ph.D., PMP – Advisor, Scientific Bio

Patrick D. Mize, Ph.D. – Advisor, Scientific Bio

David Dworaczyk, Ph.D. – Advisor, Scientific Bio

Michael Kaiser, MA – Advisor, Executive Management Bio